WALL, N.J., Feb. 21, 2012 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTCBB:BKYI), a global leader in fingerprint biometric identification solutions and advanced mobile identification technology, today reported that BIO-key's latest software release for Apple iOS products, including the iPad, iPhone and iPod Touch is now available on iTunes. "WEB-key Client" is an iTunes application that works with BIO-key's WEB-key Server for strong authentication solutions. A demo site is available at http://mobile.bio-key.com:8080/Cloud, showcasing Cloud authentication options.
In early December 2011, BIO-key made the Android release of WEB-key client available for the Motorola Atrix which offers a built in fingerprint sensor. The integration to the Android Platform completed phase two of BIO-key's mobile development platform as the company already offers solutions for the WinMobile platform. By announcing the launch of the fingerprint biometric iTunes app, the company maintains its commitment to offering state of the art biometric authentication solutions for all mobile platforms.
Recently, advanced mobile device fingerprint hardware solutions were introduced for iOS devices by Grabba, S.I.C. Biometrics and Fulcrum. Each device supports the new BIO-key iTunes application. BIO-key's iOS WEB-key client, functions with the same applications as its Win Mobile and Android counterparts, positioning BIO-key as the only software developer to offer interoperable biometric authentication solutions for the three most recognized mobile platforms. BIO-key technology offers unequaled scalability and flexibility offering users the opportunity to provide a single enrollment which allows them to authenticate from any device or usage point; users can enroll on an iPhone and authenticate on a tablet, Android phone, PC or laptop from anywhere in the world.
"Device and environment independence is a key benefit of BIO-key technology. Our goal for the past decade is maintaining that an enrollment is usable now and into the future across any and all fingerprint scanners, operating systems, devices and even applications," stated Mira LaCous, VP Technology and Development. "BIO-key offers full enrollment and identification, supported by a highly accurate algorithm and full security encryption of critical authentication data. BIO-key provides these solutions across healthcare, education, government, banking and the business enterprise," she continued.
"We are pioneering the path for securing mobile devices that is convenient and are integrated into many partner applications. The company has developed strategic relationships with IBM, CA Technologies and Oracle," said Mike DePasquale BIO-key CEO. "In healthcare we've partnered with leading EMR providers including Allscripts and EPIC who are witnessing a demand for stronger security as the iPad, a preferred device amongst physicians, is being used inside and outside the hospital for both personal and business applications; thus magnifying the risk of protecting patient records and increasing the need for convenient strong authentication," DePasquale summarized.
To see video demonstrations of BIO-key mobile solutions visit Atrix Video.
About BIO-key
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel and our ability to complete the proposed acquisition of S.I.C. Biometrics Inc. as currently planned. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2010 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.